In addition, western blot analysis revealed that proinflammatory markers NF-κB, IL-1β, and IL-6 were significantly elevated in the T2DM group but were markedly suppressed following sitagliptin treatment (Figures 5c, d). The gene discussed is NFKB1; the disease is type 2 diabetes mellitus.